Search research articles
Contact Us
Filters
Showing results (41-50 of 517) with videos related to
Page
of 52
Sort By:
The Journal of Biological Chemistry
|
November 21, 2020
The essential elements of Alzheimer's disease
Peng Lei, Scott Ayton, Ashley I Bush
The Medical Journal of Australia
|
February 10, 2022
Does the FDA-approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?
Andrew Gleason, Scott Ayton, Ashley I Bush
Pharmacology & Therapeutics
|
January 1, 1992
Beta A4 amyloid protein and its precursor in Alzheimer's disease
A I Bush, K Beyreuther, C L Masters
Molecular Psychiatry
|
January 19, 2026
Ferroptosis in neurological diseases: moving towards therapeutic intervention
Qing-Zhang Tuo, Ashley I Bush, Peng Lei
Nature Communications
|
May 20, 2015
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
Scott Ayton, Noel G Faux, Ashley I Bush, et al.
Cell Chemical Biology
|
October 21, 2017
Nanoscale Imaging Reveals Big Role for Iron in Alzheimer's Disease
Scott Ayton, Simon A James, Ashley I Bush
Neurochemistry International
|
September 18, 2012
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
Mark A Greenough, James Camakaris, Ashley I Bush
Experimental Gerontology
|
August 26, 2000
Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions
T Lynch, R A Cherny, A I Bush
Biological Psychiatry
|
May 15, 2012
Translating the Rosetta Stone of N-acetylcysteine
Olivia M Dean, Ashley I Bush, Michael Berk
Annals of the New York Academy of Sciences
|
September 24, 1993
The beta A4 amyloid protein precursor in human circulation
A I Bush, K Beyreuther, C L Masters
Page
of 52
Search research articles
Search
Showing results (41-50 of 517) with videos related to
Sort By:
Page
of 52
The Journal of Biological Chemistry
|
November 21, 2020
The essential elements of Alzheimer's disease
Peng Lei, Scott Ayton, Ashley I Bush
The Medical Journal of Australia
|
February 10, 2022
Does the FDA-approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?
Andrew Gleason, Scott Ayton, Ashley I Bush
Pharmacology & Therapeutics
|
January 1, 1992
Beta A4 amyloid protein and its precursor in Alzheimer's disease
A I Bush, K Beyreuther, C L Masters
Molecular Psychiatry
|
January 19, 2026
Ferroptosis in neurological diseases: moving towards therapeutic intervention
Qing-Zhang Tuo, Ashley I Bush, Peng Lei
Nature Communications
|
May 20, 2015
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE
Scott Ayton, Noel G Faux, Ashley I Bush, et al.
Cell Chemical Biology
|
October 21, 2017
Nanoscale Imaging Reveals Big Role for Iron in Alzheimer's Disease
Scott Ayton, Simon A James, Ashley I Bush
Neurochemistry International
|
September 18, 2012
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
Mark A Greenough, James Camakaris, Ashley I Bush
Experimental Gerontology
|
August 26, 2000
Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions
T Lynch, R A Cherny, A I Bush
Biological Psychiatry
|
May 15, 2012
Translating the Rosetta Stone of N-acetylcysteine
Olivia M Dean, Ashley I Bush, Michael Berk
Annals of the New York Academy of Sciences
|
September 24, 1993
The beta A4 amyloid protein precursor in human circulation
A I Bush, K Beyreuther, C L Masters
Page
of 52